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Abstract
Purpose The prognostic meaning of a post-stress ejection
fraction (EF) decrease detected by perfusion gated SPECT is
still unclear. We therefore followed up patients with post-stress
EF decrease in the absence of stress-induced perfusion
abnormalities.
Methods We prospectively enrolled 57 consecutive patients
with post-stress EF drop ≥5 EF units and summed difference
score (SDS)≤1. They were followed up for more than 1 year
and their outcomewas comparedwith a group of sex- and age-
matched controls with the same SDS but without EF decrease.
Results During follow-up there were 13 events (1 cardiac
death, 1 non-fatal myocardial infarction, 1 congestive heart
failure and 10 late revascularizations). In the control group
we registered six events. There was a significant difference
(p<0.0001) between the event-free survival curves of the
two groups.
ConclusionThe event rate of patients with post-stress EF
decrease≥5 EF units is relatively high and is significantly
worse than that of a control group of patients with similarly
normal SDS but without EF changes. Therefore, a post-stress
EF decrease without stress-induced perfusion abnormalities
should be cautiously interpreted.
Keywords Gated SPECT. Left ventricular ejection
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Introduction
According to the model of myocardial stunning, stress-
induced ischaemia may cause wall motion abnormalities or
a decrease in the left ventricular (LV) ejection fraction (EF)
that may be detected by comparing resting and post-stress
gated single photon emission computed tomography
(SPECT) [1]. For this reason, the presence of a post-stress
EF decrease has been indicated as an additional sign of
coronary artery disease (CAD) severity, like increased
tracer lung uptake or transient ischaemic dilatation, which
are known to have an adverse prognostic meaning [2–6].
However, a recent study has demonstrated that the post-
stress EF decrease in patients with inducible ischaemia is
usually negligible and that only a very limited percentage of
ischaemic patients have a really significant EF decrease [7].
This would imply that the value of this finding is poor, also
because of the simultaneous presence of clear ischaemic
perfusion defects [7]. On the other hand, in patients
submitted to dual gated SPECT studies a remarkable post-
stress EF decrease can be sometimes detected in the
presence of a normal or near-normal perfusion pattern. It
is therefore unclear whether an EF drop in the absence of
stress-induced perfusion defects is just a casual finding or
should be more cautiously regarded as an expression of
underlying coronary artery disease, with potential prognos-
tic implications. To clarify this issue we performed a
follow-up study of patients that presented without inducible
ischaemia but with a post-stress EF drop and we compared
their outcome with a control group of sex- and age-matched
patients similarly without inducible ischaemia but with
unchanged EF.
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This is a prospective observational study based on the
patient population that underwent stress-resting myocardial
perfusion gated SPECT in our laboratory for the standard
clinical indications between May 2004 and May 2008. The
patients were prospectively included in the follow-up
registry if they showed a ≥5 EF units decrease in post-
stress images without stress-inducible ischaemia (as below
defined) [6, 8]. Because the meaning of the EF drop was
still under investigation, it was our policy to avoid
indicating it in the clinical report. They were compared
with a sex- and age-matched control group of patients
without stress-inducible ischaemia retrospectively selected
from our data base of the year 2007, which had been
previously revised for an internal quality assessment.
Stress myocardial perfusion protocol
Patients underwent either symptom-limited exercise with a
bicycle ergometer or pharmacological stress with dipyrida-
mole infusion. Exercise was terminated when any of the
following endpoints was reached: typical anginal pain,
horizontal ST segment depression exceeding 1.0 mm in the
presence of chest pain or 3.0 mm in the absence of pain,
life-threatening arrhythmias or leg fatigue. The dosage of
dipyridamole was 0.56 mg/kg body weight over 4 min. The
protocol included the acquisition of a post-stress scan
approximately 30 min after the injection of sestamibi. The
rest gated SPECT was acquired 1 h after tracer injection
using a separate day protocol.
Gated SPECT
Gated SPECT was acquired after 99mTc-sestamibi injection
(740 MBq), using a dual-head camera (SKYlight, Philips
Medical Systems, Milpitas, CA, USA) equipped with high-
resolution collimators, 180° rotation arc, 32 projections,
60 s/projection, 8 frames/heart cycle, no arrhythmia
rejection and 64×64 matrices. The studies were recon-
structed using filtered backprojection without attenuation or
scatter correction and realigned along the heart axis. Image
evaluation was performed blindly by an experienced
observer, who was unaware of patient’s data. The LV was
divided into 17 segments and the tracer uptake was
classified using a 5-point scoring scheme (0=normal, 1=
mildly reduced, 2=moderately reduced, 3=severely re-
duced and 4=absent uptake) [9]. The summed rest score
(SRS) and the summed stress score (SSS) were obtained by
adding the scores of the 17 segments in resting and stress
images, respectively. The summed difference score (SDS)
represents the difference between the stress and resting
scores [9]. Inducible ischaemia was classified as mild (2–5),
moderate (6 –7) and severe (>7) [8]. For the purpose of the
study only patients with SDS=0 or =1 were selected. The
measurement of LV end-diastolic and end-systolic volume
and EF was performed by the QGS program (Cedars-Sinai
Medical Center, Los Angeles, CA, USA) [10]. Volumetric
data were corrected for body surface area and expressed as
indexes. The same program automatically calculated the
transient ischaemic dilation (TID) as well.
Patient follow-up
Patients were followed up by review of hospital records and
by telephone contact with the patient, relatives or referring
physician. An investigator who was unaware of perfusion
imaging results collected follow-up data. The mean follow-
up period was 22±9 months. The evaluated events were
cardiac death, non-fatal myocardial infarction, congestive
heart failure requiring hospitalization and coronary revas-
cularization >60 days after index gated SPECT.
Statistical analysis
Values are presented as mean value±standard deviation
(SD). In the case of scores, the median and the interquartile
range are indicated. Continuous variables were compared
with Student’s t test for unpaired samples or with the
Mann-Whitney U test as appropriate. The comparisons of
proportions were made using either the Fisher exact test or
the chi-square test with Yates’ correction as appropriate.
Event-free survival curves were constructed using the
Kaplan-Meier method and were compared with the log-




During the indicated time interval, 60 patients fulfilled the
selection criteria. Of them, three were lost to follow-up
because they could not be reached at their initial address.
Therefore, the final patient population included 57 patients
(24 women, mean age 67.3±10 years). The indications for
myocardial perfusion imaging (MPI) were: (1) diagnosis of
coronary artery disease in patients with intermediate pre-
test probability (20 patients), (2) worsening of anginal
symptoms in chronic coronary artery disease or evaluation
of anginal symptoms in prior myocardial infarction (8
patients), (3) evaluation of chest pain in previous revascu-
larization (21 patients) and (4) evaluation prior to major
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non-cardiac surgery (8 patients). The stress test used was
exercise in 36 and dipyridamole in 21 patients.
The control group included 57 sex- and age-matched
patients (23 women, mean age 67.2±9.4 years). As shown
in Table 1, the control group was comparable with the study
group in terms of risk factor profile, previous clinical
history, indication for perfusion imaging and type of stress
testing.
Gated SPECT findings
In the study group, the resting gated SPECTwas normal in 41
patients and abnormal in 10, with a median SRS of 0 (0–0).
The resting EF was 63±10%. In stress gated SPECT, the SSS
was 0 in 41 patients and ≥1 in 16, with a median of 0 (0–0.5).
The post-stress EF was 55±10%. The delta EF was −8±3%.
The TID was 1.06±0.13. Table 2 compares the gated SPECT
findings of the study group with those of the control group.
In particular, no significant difference in the other stress
parameters with prognostic relevance was registered. There
was a trend to a higher rate of anginal symptoms (28 vs 12%,
p=0.06) and of patients with post-stress EF<50% (28 vs
12%, p=0.06) in the cases versus the control group.
Follow-up data
During follow-up among the patients with EF drop there
were one cardiac death, one non-fatal myocardial infarc-
tion, one congestive heart failure and ten delayed revascu-
larizations: four coronary artery bypass grafting (CABG)
and six percutaneous coronary interventions (PCI). Con-
versely, in the control group we registered one non-fatal
myocardial infarction followed by revascularization
(CABG) and five delayed revascularizations (one CABG
and four PCI). Figure 1 compares the survival curves in the
patients with EF drop versus the controls, showing a highly
significant difference (p<0.0001) between the two groups
in terms of event-free survival. Conversely, there was no
difference if the whole patient population was stratified on
the basis of the type of stress test and of the presence of
resting EF <50%. If the patients were divided into those
with versus those without post-stress EF < 50%, there was a
borderline significant difference in the event-free survival
group in favour of the latter group (p<0.05).
Discussion
Results of the present study
The main result of the present study is that in a patient
population selected on the basis of the finding of a post-
stress decrease in gated SPECT EF≥5 EF units, but without
inducible ischaemia, there was a relatively high rate of
cardiac events. In particular, there was a significantly higher
rate of events than in an age- and sex-matched control
group of patients without detectable inducible ischaemia
and with unchanged EF after stress.
Table 1 Clinical characteristics of the patient population
EF drop (n=57) No EF drop (n=57) p
Age, years, mean±SD 67.3±10 67.2±9.4 NS
Female sex, n (%) 24 (42) 23 (40) NS
Family history of CAD, n (%) 35 (61) 33 (58) NS
Systemic hypertension, n (%) 51 (89) 45 (79) NS
Hypercholesterolaemia (total cholesterol>200 mg/dl), n (%) 33 (58) 33 (58) NS
History of smoking, n (%) 35 (61) 31 (54) NS
Diabetes mellitus, n (%) 21 (37) 15 (26) NS
Prior coronary artery bypass grafting, n (%) 5 (9) 5 (9) NS
Prior percutaneous coronary intervention, n (%) 16 (28) 17 (30) NS
Recent coronary angiography
One-vessel disease, n (%) 5 (9) 4 (7) NS
Multi-vessel disease, n (%) 14 (25) 9 (16) NS
Indication for stress MPI
Diagnosis of suspected CAD, n (%) 20 (35) 24 (42) NS
Evaluation in known CAD, prior infarction, n (%) 8 (14) 7 (12) NS
Evaluation in prior revascularization, n (%) 21 (37) 17 (32) NS
Evaluation before major non-cardiac surgery, n (%) 8 (14) 9 (16) NS
Pharmacological stress, n (%) 21 (37) 21 (37) NS
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Comparison with previous studies
To the best of our knowledge, there are no other studies that
specifically examined the outcome of patients with post-
stress EF decrease in the absence of perfusion abnormali-
ties. Several prior reports indicated that patients with
normal or near-normal stress perfusion have an excellent
prognosis [11–16]. According to all these studies, the
outcome of patients with normal perfusion is excellent,
and the same is true for those with very mild perfusion
abnormalities. Indeed, in our control group, the event rates
(1.5% for hard events and 9% for soft events) appear higher
than those reported in the literature, but this difference can
be explained by the features of our cohort, which showed a
quite severe risk factor profile and included a large
proportion of patients with known coronary artery disease,
and by the fact that we focused our selection criteria on the
normality of SDS as an expression of stress-induced
perfusion changes and not on the absence of perfusion
abnormalities altogether. It is therefore even more intrigu-
ing that in our patient population with EF drop the event
rate appears to be significantly higher than in controls, with
an incidence of 5% for hard events and of 17.5% for soft
events. These values appear at least comparable and
possibly superior to those previously reported for patients
with mild to moderate perfusion abnormalities [8, 17, 18].
Clinical implications
Similarly to increased lung uptake and TID, the presence of
a major EF drop after stress is commonly considered as a
sign of severe coronary artery disease, but the meaning of a
borderline post-stress EF decrease has been recently
questioned [1, 2, 4, 6, 7]. Conversely, our results indicate
that the prognosis of patients with this finding and without
inducible ischaemia is significantly worse than in compa-
Table 2 Gated SPECT findings
EF drop (n=57) No EF drop (n=57) p
Maximal exercise workload (W), mean±SD 90±24 92±26 NS
Maximal heart rate (bpm), mean±SD 122±26 127±26 NS
Peak systolic blood pressure (mmHg), mean±SD 182±30 185±30 NS
Peak diastolic blood pressure (mmHg), mean±SD 96±14 92±12 NS
Rate-pressure product, mean±SD 22,590±7,009 23,867±7,333 NS
Typical angina, n (%) 16 (28%) 7 (12%) = 0.06
Ischaemic electrocardiographic changes, n (%) 12 (21%) 8 (14%) NS
SRS, median (interquartile range) 0 (0–0) 0 (0–0) NS
SSS, median (interquartile range) 0 (0–0.5) 0 (0–0.5) NS
SDS, median (interquartile range) 0 (0–0) 0 (0–0) NS
Resting EF, mean±SD 63±10% 60±11% NS
Resting EF<50%, n (%) 6 (11%) 9 (16%) NS
Resting end-diastolic volume index (ml/m2), mean±SD 46±14 47±17 NS
Resting end-systolic volume index (ml/m2), mean±SD 19±11 21±14 NS
Post-stress EF, mean±SD 55±10% 62±11% < 0.005
Post-stress EF<50%, n (%) 16 (28%) 7 (12%) = 0.06
Delta EF, mean±SD −8±3% 1.6±2% < 0.00001
TID, mean±SD 1.06±0.13 0.93±0.12 < 0.00001
p < 0.0001
Fig. 1 Event-free survival curves for the patients with (solid line)
versus those without (dashed line) EF drop≥5 EF units
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rable patients with the same perfusion pattern but with
stable EF. This would imply that a clear EF decrease even
though registered in the absence of inducible perfusion
defects should be considered as a potential indirect sign of
coronary artery disease and prompt further investigations or
at least a more attentive clinical follow-up. It must be noted
that the resting EF was unable to identify the patients with
higher probability of events. Conversely, the finding of a
post-stress EF<50% selected a high-risk group as well,
but the difference between the event-free survival curves
was clearly lower than in the case of EF drop. However,
there is a relationship between the presence of EF drop
and of abnormal post-stress EF. In practical terms, both
findings suggest that the statement that post-stress and
resting EF values may be considered equivalent is not
always true.
Mechanisms of EF decrease
As already mentioned, post-ischaemic stunning explains the
occurrence of functional abnormalities in patients that
underwent exercise stress testing. The presence of multi-
vessel coronary artery disease with ischaemia in more than
one territory could justify the lack of detectable perfusion
defects together with global functional impairment in these
subjects. However, it is noteworthy that these findings have
been registered also in patients that underwent vasodilator
instead of physical stress. It was already known that
functional changes may be observed and have diagnostic
value in the setting of vasodilator stress as well as after
exercise [4, 5]. Furthermore, recent data based on the EF
calculated using gated PET after adenosine or dipyridamole
infusion support the concept that abnormalities in stress-
induced functional response may play an important diag-
nostic role even in the instance of vasodilator stimulation
[19, 20]. These observations suggest that in the patients
with EF drop true diffuse ischaemia without regional
perfusion inhomogeneities could occur, leading to transient
functional impairment.
Study limitations
The limitations of the present study must be considered.
First of all the patient population of this exploratory study
is quite small, and its results must be regarded as
preliminary and should be confirmed in a prospective study
on a wider cohort. The population from which we enrolled
our patients was unselected and the type of stress testing
was not the same in all patients. This offers the advantage
that our study cohort is close to common practice, but,
together with the fact that the study protocol did not include
coronary angiography as reference standard, prevents an
exact definition of the mechanisms that cause the EF
changes. Indeed, other factors than disseminate and severe
coronary artery disease leading to diffuse ischaemia as
above hypothesized, such as coronary microvascular
dysfunction in hypertensive heart disease or diabetic
microangiopathy, could have played a role in determining the
decrease in EF after stress. The relatively high rate of
hypertensive and diabetic patients in our series, although not
significantly different than that in the control group, could
justify this hypothesis. We did not perform any arrhythmia
rejection and therefore we cannot exclude that transient
rhythm disturbances during the acquisition could have
influenced the EF calculation. However, previous data
indicate that the influence of arrhythmia rejection on the
functional parameters derived from gated SPECT is limited
[21]. Because we adopted a relatively low threshold for
classifying the EF response as abnormal, the gated SPECT
reproducibility is a major issue. However, both literature data
and our prior direct experience indicate that in general the
reproducibility of gated SPECT is high enough to make the
5% cutoff clinically reliable [6, 22–24].
Conclusion
Our results indicate that the event rate of a patient
population without inducible ischaemia selected on the
basis of a post-stress EF decrease≥5 EF units is relatively
high as compared to that of patients with similar perfusion
but without EF drop. Therefore, the finding of a clear post-
stress EF decrease, even though registered in the absence of
stress-induced perfusion abnormalities, should be attentive-
ly evaluated and cautiously interpreted taking into account
the individual patient’s clinical context.
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